The dCas9-HDAC fusion protein has been used in further studies to target the DPP4 promoter, reducing histone acetylation, inhibiting DPP4 (Dipeptidyl peptidase-4) expression and significantly reducing tumor growth and metastasis. The gene discussed is DPP4; the disease is neoplasm.